254 related articles for article (PubMed ID: 16014318)
21. Preparation and passive target of 5-fluorouracil solid lipid nanoparticles.
Du B; Yan Y; Li Y; Wang S; Zhang Z
Pharm Dev Technol; 2010; 15(4):346-53. PubMed ID: 19769532
[TBL] [Abstract][Full Text] [Related]
22. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.
Hanafy A; Spahn-Langguth H; Vergnault G; Grenier P; Tubic Grozdanis M; Lenhardt T; Langguth P
Adv Drug Deliv Rev; 2007 Jul; 59(6):419-26. PubMed ID: 17566595
[TBL] [Abstract][Full Text] [Related]
24. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
25. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
[TBL] [Abstract][Full Text] [Related]
26. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
27. [Preparation of tetrandrine solid lipid nanoparticles].
Li YC; Dong L; Jia A; Chang XM; Xue H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):686-9. PubMed ID: 17121232
[TBL] [Abstract][Full Text] [Related]
28. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
Zhang WL; Liu JP; Liu XX; Chen ZQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
[TBL] [Abstract][Full Text] [Related]
29. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
[TBL] [Abstract][Full Text] [Related]
30. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.
Varshosaz J; Tabbakhian M; Mohammadi MY
J Liposome Res; 2010 Dec; 20(4):286-96. PubMed ID: 19958118
[TBL] [Abstract][Full Text] [Related]
31. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain.
Gupta Y; Jain A; Jain SK
J Pharm Pharmacol; 2007 Jul; 59(7):935-40. PubMed ID: 17637187
[TBL] [Abstract][Full Text] [Related]
32. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement.
Sanjula B; Shah FM; Javed A; Alka A
J Drug Target; 2009 Apr; 17(3):249-56. PubMed ID: 19255893
[TBL] [Abstract][Full Text] [Related]
33. Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration.
Ren J; Zou M; Gao P; Wang Y; Cheng G
Eur J Pharm Biopharm; 2013 Feb; 83(2):141-8. PubMed ID: 23201052
[TBL] [Abstract][Full Text] [Related]
34. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
35. Effects of green tea extract administration on the pharmacokinetics of clozapine in rats.
Jang EH; Choi JY; Park CS; Lee SK; Kim CE; Park HJ; Kang JS; Lee JW; Kang JH
J Pharm Pharmacol; 2005 Mar; 57(3):311-6. PubMed ID: 15807986
[TBL] [Abstract][Full Text] [Related]
36. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
[TBL] [Abstract][Full Text] [Related]
37. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X
Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443
[TBL] [Abstract][Full Text] [Related]
38. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP
Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
[TBL] [Abstract][Full Text] [Related]
39. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil.
Sharma P; Ganta S; Denny WA; Garg S
Int J Pharm; 2009 Feb; 367(1-2):187-94. PubMed ID: 18930127
[TBL] [Abstract][Full Text] [Related]
40. [The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles].
Zhang DR; Ren TC; Lou HX; Xing J
Yao Xue Xue Bao; 2005 Jun; 40(6):573-6. PubMed ID: 16144328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
